UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 97

Sortiert nach

A novel polymorphism in ABCB1 gene, CYP2B66 and sex predict single‐dose efavirenz population pharmacokinetics in Ugandans

British journal of clinical pharmacology, 2009-11, Vol.68 (5), p.690-699

2009

Volltextzugriff (PDF)

A novel mutation in the biliverdin reductase‐A gene combined with liver cirrhosis results in hyperbiliverdinaemia (green jaundice)

Liver international, 2009-08, Vol.29 (7), p.1116-1124

2009

Volltextzugriff (PDF)

Determination of phenprocoumon, warfarin and their monohydroxylated metabolites in human plasma and urine by liquid chromatography–mass spectrometry after solid-phase extraction

Journal of chromatography. B, Analytical technologies in the biomedical and life sciences, 2004-10, Vol.809 (2), p.217-226

2004

Volltextzugriff (PDF)

Disposition of fluvoxamine in humans is determined by the polymorphic CYP2D6 and also by the CYP1A2 activity

Clinical pharmacology and therapeutics, 1996-08, Vol.60 (2), p.183-190

1996

Volltextzugriff (PDF)

Plasma concentrations of haloperidol are related to CYP2D6 genotype at low, but not high doses of haloperidol in Korean schizophrenic patients

British journal of clinical pharmacology, 2001-09, Vol.52 (3), p.265-271

2001

Volltextzugriff (PDF)

Simultaneous quantification of alprazolam, 4- and α-hydroxyalprazolam in plasma samples using liquid chromatography mass spectrometry

Journal of chromatography. B, Analytical technologies in the biomedical and life sciences, 2005-01, Vol.814 (1), p.127-131

2005

Volltextzugriff (PDF)

Cerebrospinal fluid HIV-1 RNA, intrathecal immunoactivation, and drug concentrations after treatment with a combination of saquinavir, nelfinavir, and two nucleoside analogues: the M61022 study

BMC infectious diseases, 2006-03, Vol.6 (1), p.63-63, Article 63

2006

Volltextzugriff (PDF)

Risperidone metabolism in relation to CYP2D610 allele in Korean schizophrenic patients

European journal of clinical pharmacology, 2001-11, Vol.57 (9), p.671-675

2001

Volltextzugriff (PDF)

Determination of ribavirin in serum using highly selective solid-phase extraction and high-performance liquid chromatography

Therapeutic drug monitoring, 2000-04, Vol.22 (2), p.215-218

2000

Volltextzugriff (PDF)

Efavirenz plasma concentrations in HIV-infected patients: inter- and intraindividual variability and clinical effects

Therapeutic drug monitoring, 2004-06, Vol.26 (3), p.267

2004

Volltextzugriff (PDF)

The aciclovir metabolite CMMG is detectable in the CSF of subjects with neuropsychiatric symptoms during aciclovir and valaciclovir treatment

Journal of antimicrobial chemotherapy, 2006-05, Vol.57 (5), p.945-949

2006

Volltextzugriff (PDF)

CYP2D6 genotype in relation to perphenazine concentration and pituitary pharmacodynamic tissue sensitivity in Asians: CYP2D6–serotonin–dopamine crosstalk revisited

Pharmacogenetics and genomics, 2007-05, Vol.17 (5), p.339-347

2007

Volltextzugriff (PDF)

Dennis Sandell (1960–2020)

Advanced drug delivery reviews, 2021-09, Vol.176, p.113894-113894, Article 113894

2021

Volltextzugriff (PDF)

High serum concentrations of the acyclovir main metabolite 9‐carboxymethoxymethylguanine in renal failure patients with acyclovir‐related neuropsychiatric side effects: an observational study

Nephrology, dialysis, transplantation, 2003-06, Vol.18 (6), p.1135-1141

2003

Volltextzugriff (PDF)

Maintenance therapy with zuclopenthixol decanoate: associations between plasma concentrations, neurological side effects and CYP2D6 genotype

Psychopharmacology, 2002-06, Vol.162 (1), p.67-73

2002

Volltextzugriff (PDF)

Indinavir-based treatment of HIV-1 infected patients : efficacy in the central nervous system

AIDS (London), 1999-07, Vol.13 (10), p.1227-1232

1999

Volltextzugriff (PDF)

Comparison of the antinociceptive effect of morphine, methadone, buprenorphine and codeine in two substrains of Sprague–Dawley rats

European journal of pharmacology, 2004-05, Vol.492 (1), p.27-34

2004

Volltextzugriff (PDF)

Determination of morphine, morphine-3-glucuronide and (tentatively) morphine-6-glucuronide in plasma and urine using ion-pair high-performance liquid chromatography

Journal of chromatography, 1982-07, Vol.230 (2), p.427-432

1982

Volltextzugriff (PDF)

Interpretation of the presence of 6-monoacetylmorphine in the absence of morphine-3-glucuronide in urine samples: Evidence of heroin abuse

Therapeutic drug monitoring, 2003-10, Vol.25 (5), p.645-648

2003

Volltextzugriff (PDF)

Alprazolam as a probe for CYP3A using a single blood sample : pharmacokinetics of parent drug, and of α- and 4-hydroxy metabolites in healthy subjects

European journal of clinical pharmacology, 2005-04, Vol.61 (2), p.113-118

2005

Volltextzugriff (PDF)

Effect of a spacer on total systemic and lung bioavailability in healthy volunteers and in vitro performance of the Symbicort® (budesonide/formoterol) pressurized metered dose inhaler

Pulmonary pharmacology & therapeutics, 2018-10, Vol.52, p.7-17

2018

Volltextzugriff (PDF)

A simple HPLC method for simultaneous determination of mycophenolic acid and mycophenolic acid glucuronide in plasma

Therapeutic drug monitoring, 1999-06, Vol.21 (3), p.322-324

1999

Volltextzugriff (PDF)

Determination of LSD in urine with high-performance liquid chromatography-mass spectrometry

Therapeutic drug monitoring, 2001-08, Vol.23 (4), p.389-393

2001

Volltextzugriff (PDF)

Determination of ketobemidone and its metabolites in plasma and urine using solid-phase extraction and liquid chromatography-mass spectrometry

Therapeutic drug monitoring, 2001-08, Vol.23 (4), p.399-405

2001

Volltextzugriff (PDF)

Determination of morphine, morphine-6-glucuronide and normorphine in plasma and urine with high-performance liquid chromatography and electrochemical detection

Journal of chromatography, 1986, Vol.375 (1), p.174-178

Svensson, Jan-Olof

1986

Volltextzugriff (PDF)

1 – 25 von 97

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(74)
Mit Volltextzugriff
(90)

Publikationsform

Sprache

Erscheinungsjahr

n.n

Thema

Science & Technology
(66)
Life Sciences & Biomedicine
(56)
Humans
(52)
Biological And Medical Sciences
(42)
Medical Sciences
(39)
Medicin Och Hälsovetenskap
(35)
Male
(31)
Pharmacology. Drug Treatments
(31)
Female
(27)
Pharmacology & Pharmacy
(26)
Adult
(21)
Middle Aged
(18)
Physical Sciences
(14)
General Pharmacology
(13)
Chromatography, High Pressure Liquid
(10)
Toxicology
(10)
Analysis
(9)
Chemistry
(9)
Fundamental And Applied Biological Sciences. Psychology
(9)
Neuropharmacology
(9)

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

A novel polymorphism in ABCB1 gene, CYP2B66 and sex predict single‐dose efavirenz population pharmacokinetics in Ugandans

A novel mutation in the biliverdin reductase‐A gene combined with liver cirrhosis results in hyperbiliverdinaemia (green jaundice)

Determination of phenprocoumon, warfarin and their monohydroxylated metabolites in human plasma and urine by liquid chromatography–mass spectrometry after solid-phase extraction

Disposition of fluvoxamine in humans is determined by the polymorphic CYP2D6 and also by the CYP1A2 activity

Plasma concentrations of haloperidol are related to CYP2D6 genotype at low, but not high doses of haloperidol in Korean schizophrenic patients

Simultaneous quantification of alprazolam, 4- and α-hydroxyalprazolam in plasma samples using liquid chromatography mass spectrometry

Cerebrospinal fluid HIV-1 RNA, intrathecal immunoactivation, and drug concentrations after treatment with a combination of saquinavir, nelfinavir, and two nucleoside analogues: the M61022 study

Risperidone metabolism in relation to CYP2D610 allele in Korean schizophrenic patients

Determination of ribavirin in serum using highly selective solid-phase extraction and high-performance liquid chromatography

Efavirenz plasma concentrations in HIV-infected patients: inter- and intraindividual variability and clinical effects

The aciclovir metabolite CMMG is detectable in the CSF of subjects with neuropsychiatric symptoms during aciclovir and valaciclovir treatment

CYP2D6 genotype in relation to perphenazine concentration and pituitary pharmacodynamic tissue sensitivity in Asians: CYP2D6–serotonin–dopamine crosstalk revisited

Dennis Sandell (1960–2020)

High serum concentrations of the acyclovir main metabolite 9‐carboxymethoxymethylguanine in renal failure patients with acyclovir‐related neuropsychiatric side effects: an observational study

Maintenance therapy with zuclopenthixol decanoate: associations between plasma concentrations, neurological side effects and CYP2D6 genotype

Indinavir-based treatment of HIV-1 infected patients : efficacy in the central nervous system

Comparison of the antinociceptive effect of morphine, methadone, buprenorphine and codeine in two substrains of Sprague–Dawley rats

Determination of morphine, morphine-3-glucuronide and (tentatively) morphine-6-glucuronide in plasma and urine using ion-pair high-performance liquid chromatography

Interpretation of the presence of 6-monoacetylmorphine in the absence of morphine-3-glucuronide in urine samples: Evidence of heroin abuse

Alprazolam as a probe for CYP3A using a single blood sample : pharmacokinetics of parent drug, and of α- and 4-hydroxy metabolites in healthy subjects

Effect of a spacer on total systemic and lung bioavailability in healthy volunteers and in vitro performance of the Symbicort® (budesonide/formoterol) pressurized metered dose inhaler

A simple HPLC method for simultaneous determination of mycophenolic acid and mycophenolic acid glucuronide in plasma

Determination of LSD in urine with high-performance liquid chromatography-mass spectrometry

Determination of ketobemidone and its metabolites in plasma and urine using solid-phase extraction and liquid chromatography-mass spectrometry

Determination of morphine, morphine-6-glucuronide and normorphine in plasma and urine with high-performance liquid chromatography and electrochemical detection

Suchergebnisse filtern